A clinical study for individuals with Duchenne Muscular Dystrophy (“Duchenne”)
The search for a new treatment begins with you!
The SHIELD DMD study will look at the effects, good or bad, of a study medicine called satralizumab in young people with Duchenne who are currently on daily corticosteroids.